The Company will provide an investor update in connection with the refinement of Clinical Focus into Chronic Lung Disease Treatment.
The presentation will be held at https://investorweb.no/ir-channel/SOFTX/event/bb11f388-9ecb-4022-a43a-74c202b54cf9 on Monday, September 8, at 10:00 AM.
The presentation will be recorded and made available afterwards.
The presenters from the company will be:
Ulrik Spork, COB
Thomas Bjarnsholt, CEO
Welcome.